All press releases

VitalBio CEO Featured in Forbes on the Future of Personalized Healthcare

Breakthrough biotech firm raises $60M to scale personalized health diagnostics globally.

VitalBio's chief executive was profiled in Forbes this week in a feature examining how diagnostics built around individual patient data are reshaping early-stage care. The interview covered the company's clinical pipeline, its partnership model with regional hospital groups and the practical limits of personalization at scale. The article follows VitalBio's $60M growth round, which the company says will fund laboratory capacity in three markets and double its clinical affairs team. PRCOM led the announcement strategy, including exclusive placement, executive media training and a supporting data briefing for healthcare trade press. "What made this story work was restraint," said the PRCOM account director. "We did not pitch a funding milestone. We pitched a point of view about how care gets decided, and the coverage followed the argument rather than the cheque."
About PRCOM — PRCOM is an independent PR and communications agency working with technology, healthcare, finance and climate companies. The agency builds earned-media strategies, executive positioning programmes and crisis playbooks for leadership teams that need to stay visible and credible.